I agree that this site is using cookies. You can find further informations here.
X
O'Byrne, K.
658  results:
Search for persons X
?
1

Poor patient outcome correlates with active engulfment of c..:

Wiegmans, A. P. ; Ivanova, E. ; Naei, V. Y....
Clinical & Experimental Metastasis.  41 (2024)  3 - p. 219-228 , 2024
Link: https://doi.org/10.1007/..
 
?
2

ALKTERNATE: A pilot study alternating lorlatinib with crizo..:

Itchins, M. ; Liang, S. ; Brown, C....
JTO Clinical and Research Reports.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Nivolumab plus chemotherapy in first-line metastatic non-sm..:

Borghaei, H. ; O'Byrne, K.J. ; Paz-Ares, L....
ESMO Open.  8 (2023)  6 - p. 102065 , 2023
Link: https://doi.org/10.1016/..
 
?
4

EP11.03-23 Efficacy of Nivolumab + Ipilimumab Vs other Firs..:

O'Byrne, K. ; Popoff, E. ; Badin, F....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S629-S630 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P2.10-01 ALKTERNATE: A Pilot Study Alternating Lorlatinib w..:

Itchins, M. ; Liang, S. ; Brown, C....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S351-S352 , 2023
Link: https://doi.org/10.1016/..
 
?
6

EP08.02-02 Real World Chemoradiotherapy Outcomes for Frail ..:

Fletcher, J. ; Pringle, N. ; Mullally, W....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S568 , 2023
Link: https://doi.org/10.1016/..
 
?
7

EP13.06-02 hSSB1 is Elevated and a Potential Target for The..:

O'Byrne, K. ; Burgess, J. ; Suraweera, A...
Journal of Thoracic Oncology.  18 (2023)  11 - p. S703-S704 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P2.06-09 Association of Clinical Response and HRQoL with Lo..:

Reck, M. ; Worthy, G. ; Yuan, Y....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S320-S321 , 2023
Link: https://doi.org/10.1016/..
 
?
9

OA14.03 Six-year Survival and HRQoL Outcomes with 1L Nivolu..:

Ramalingam, S.S. ; Ciuleanu, T.-E. ; Bernabe Caro, R....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S76-S77 , 2023
Link: https://doi.org/10.1016/..
 
?
10

OA09.04 ILLUMINATE: Efficacy and Safety of Durvalumab-Treme..:

Lee, C. ; Liao, B.-C. ; Subramaniam, S....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S63 , 2023
Link: https://doi.org/10.1016/..
 
?
11

MA09.03 High-Dimensional Profiling of the Tumour Microenvir..:

Kulasinghe, A. ; Monkman, J. ; Moradi, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S129 , 2023
Link: https://doi.org/10.1016/..
 
?
12

41P Efficacy of first-line (1L) nivolumab (N) + ipilimumab ..:

Borghaei, H. ; Balli, D. ; Paz-Ares, L....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S64-S65 , 2023
Link: https://doi.org/10.1016/..
 
?
13

EP08.02-03 Real World Experience of Survival Outcomes in Co..:

Pringle, N. ; Fletcher, J.A. ; Morton, C....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S569 , 2023
Link: https://doi.org/10.1016/..
 
?
14

P1.23-04 Extracellular Small Vesicle Phosphorylated PD-L1 L..:

O'Byrne, K. ; Shanmugasundaram, K.B. ; Ahmed, E....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S256 , 2023
Link: https://doi.org/10.1016/..
 
?
15

EP11.03-20 Real World Experience of First Line Pembrolizuma..:

Fletcher, J. ; Mullally, W.J. ; Berman, C....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S628-S629 , 2023
Link: https://doi.org/10.1016/..
 
1-15